• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives Isoquinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoquinolines and derivatives

Recent Advances in the Study of 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride (CAS: 365998-39-6)

7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride (CAS: 365998-39-6) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, known for its unique structural properties, has been the subject of numerous studies aimed at exploring its potential applications in drug discovery and development. Recent research has focused on its synthesis, biological activity, and potential therapeutic uses, making it a key area of investigation for researchers in the field.

A recent study published in the Journal of Medicinal Chemistry (2023) highlighted the compound's role as a versatile intermediate in the synthesis of novel isoquinoline derivatives. The study demonstrated that 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride can be efficiently modified to produce compounds with enhanced biological activity, particularly in targeting specific enzymes involved in inflammatory pathways. The researchers utilized advanced spectroscopic techniques, including NMR and mass spectrometry, to confirm the structural integrity of the synthesized derivatives.

Another significant development was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, which explored the compound's potential as a kinase inhibitor. The study revealed that derivatives of 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride exhibited promising inhibitory activity against several kinases implicated in cancer progression. Molecular docking studies further supported these findings, suggesting a strong interaction between the compound and the ATP-binding sites of the target kinases.

In addition to its pharmacological potential, recent advancements in the scalable synthesis of 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride have been reported. A 2023 study in Organic Process Research & Development detailed an optimized synthetic route that improves yield and reduces production costs, making the compound more accessible for large-scale applications. This development is particularly relevant for pharmaceutical companies looking to incorporate the compound into their drug development pipelines.

Looking ahead, researchers are increasingly focusing on the translational potential of 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride. Ongoing preclinical studies are evaluating its efficacy and safety in animal models, with preliminary results indicating favorable pharmacokinetic profiles. These findings underscore the compound's potential as a lead candidate for the development of new therapeutics targeting a range of diseases, from inflammatory disorders to oncology.

In conclusion, the latest research on 7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride (CAS: 365998-39-6) highlights its growing importance in chemical biology and pharmaceutical sciences. With continued advancements in synthesis, biological evaluation, and translational research, this compound is poised to play a pivotal role in the discovery of next-generation drugs. Future studies will likely focus on further elucidating its mechanism of action and expanding its therapeutic applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)